Family of bacteriostatic antibiotics that inhibit protein synthesis by binding to the large subunit of the bacterial ribosome; includes erythromycin, clindamycin, chloramphenicol (rarely used because of adverse side effects), and the new drugs clarithromycin and azithromycin.